Crista Galli Ventures

Crista Galli Ventures is a venture capital firm established in 2019, with offices in Copenhagen, Denmark, and London, United Kingdom. The firm focuses on investing in early-stage startups, particularly in the health technology, digital health, and deep technology sectors. Crista Galli Ventures provides patient capital to support companies at the pre-seed, seed, and Series A stages, typically investing up to £0.5 million at the seed level and up to £3 million at the Series A level. The firm prioritizes investments in pan-European companies, aiming to foster innovation and growth in the healthcare landscape.

Søren Fryland Møller

Partner

32 past transactions

Vitrue Health

Seed Round in 2024
Vitrue Health specializes in digital technology aimed at reducing musculoskeletal issues through accurate measurement and assessment. The company's flagship products, including VIDA and Vitrue EVVA, utilize advanced computer vision and biomechanics to objectively evaluate musculoskeletal health in various settings, from workplaces to clinical environments. VIDA specifically addresses the needs of desk workers by assessing their workspaces and ensuring compliance with ergonomic standards, helping to mitigate common problems like back and neck pain. Vitrue EVVA employs depth sensors for clinical-grade evaluations, which are valuable in orthopaedics, injury prevention in elite sports, and health screenings. By providing detailed reports and predictive insights regarding functional ability and core strength, Vitrue Health empowers both clinicians and patients to identify issues early, design optimal treatment plans, and engage patients in their recovery. The company’s mission is to establish a new foundation for musculoskeletal healthcare, aiming to alleviate pain and improve the quality of life for millions.

Jude

Seed Round in 2023
Jude is a healthcare company focused on addressing bladder-related issues and raising awareness about incontinence. It provides a range of bladder care solutions, including access to medical specialists who offer advice through social media platforms, virtual workshops, and private chat sessions. In addition to educational resources, Jude supplies health products designed to help individuals understand their conditions and manage them effectively. By promoting open discussions and providing expert guidance, Jude aims to empower individuals to lead leak-free lives and break the stigma surrounding bladder health.

Collective Minds Radiology

Venture Round in 2023
Collective Minds Radiology is a cloud-based healthcare company specializing in radiology services that facilitate collaboration and consultation among medical professionals. The company provides a platform that enables radiologists to share imaging cases with peers and access expert advice, thereby enhancing the diagnostic process. Their innovative workspace integrates collective intelligence and artificial intelligence, allowing healthcare professionals to improve clinical audits and maintain high-quality standards in imaging. This approach supports the creation of a comprehensive reference library for enhanced analysis and promotes continuous education and research within the field of radiology.

Gleamer

Series B in 2023
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Pear Bio

Series A in 2023
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

52 North

Seed Round in 2023
52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

Subtle Medical

Series B in 2022
Subtle Medical, Inc. is a healthcare technology company based in Menlo Park, California, specializing in AI-powered medical imaging solutions. Founded in 2017, the company develops innovative software products such as SubtleMR and SubtlePET, which are designed to enhance image quality in magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. These products utilize proprietary deep learning algorithms to reduce image noise and improve sharpness, thereby increasing efficiency and safety in clinical workflows. Subtle Medical's technology is FDA cleared and CE marked, and it operates on a vendor-agnostic AI infrastructure that integrates seamlessly with existing imaging systems. The company's mission is to enhance the quality, value, and accessibility of medical imaging by lowering costs, reducing imaging time, and minimizing radiation and contrast doses for patients.

Surgery Hero

Seed Round in 2022
Surgery Hero is a pioneering digital prehabilitation clinic that focuses on preparing individuals for surgery and facilitating their recovery in the comfort of their homes. The company offers a digital care platform designed for surgery preparation, perioperative care, and post-operative recovery. By utilizing expert health coaches and providing digital guidance, Surgery Hero helps clients adopt lifestyle habits that are scientifically proven to enhance surgical outcomes. This approach not only optimizes both physical and mental readiness prior to surgery but also aims to reduce the risk of complications and accelerate the recovery process.

CardiaTec Biosciences

Pre Seed Round in 2022
CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Adni

Seed Round in 2022
Adni is transforming the career management landscape for healthcare workers by offering an all-in-one AI-powered super app. This innovative platform streamlines various aspects of a healthcare worker's professional life, including job matching, credential updates, networking opportunities, and ongoing education. Adni's AI agents function as career copilots, assisting healthcare professionals in saving time and money. For employers, Adni provides a unique solution that not only facilitates recruitment from its extensive professional network but also focuses on talent retention. The platform enables healthcare organizations to create a customized engagement experience for clinicians, allowing them to access necessary resources, earn rewards, and find wellness support—all in one place. By prioritizing both recruitment and retention, Adni aims to foster a satisfied and engaged workforce in the healthcare sector.

Anja

Seed Round in 2022
Anja Health is a personalized, doctor-backed company specializing in umbilical cord blood and placenta stem cell banking. It offers a convenient service for expecting parents by providing a collection kit to facilitate the preservation of stem cells immediately after birth. Anja Health allows for up to two minutes of delayed cord clamping, ensuring that the collection of stem cells is performed safely. Once the birth occurs, parents can notify Anja's team using the contact number on the kit, prompting a medical courier to collect and swiftly transport the kit to a lab within 72 hours. The company aims to make the preservation of these vital stem cells both easy and affordable, empowering parents with knowledge about stem cell banking and its potential benefits for future medical treatments.

52 North

Seed Round in 2022
52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

Apryl

Seed Round in 2022
Apryl is a fertility benefits platform designed to address inequalities in employee support related to family planning. The company provides a comprehensive suite of services aimed at helping employers attract and retain top talent while promoting diversity and inclusion in the workplace. Its offerings include consultations, access to clinics, and various treatments such as egg freezing, in vitro fertilization (IVF), and adoption assistance. By facilitating these benefits, Apryl enables employees to receive the necessary support from their employers in a safe and confidential manner.

Noula

Pre Seed Round in 2022
Noula is a healthcare technology company specializing in hormonal health. It empowers patients, particularly those preparing for or undergoing pregnancy, by providing personalized health insights derived from unique data including hormone biomarkers, genetics, nutrition, and lifestyle factors. Noula offers at-home test kits and custom wellness plans, supported by virtual, one-on-one coaching from empathetic clinicians to facilitate nutritional planning and promote overall well-being throughout the reproductive journey.

LEIA Health

Angel Round in 2021
LEIA Health is a company that specializes in developing a postpartum support application for new parents. The app is designed to ease the transition into parenthood by offering personalized insights into both mental and physical health. It features medically validated information and tools that optimize health, including screening models for postpartum depression and pelvic floor complications. This enables women to identify potential risks at an earlier stage and connects them with appropriate healthcare providers. Through its innovative approach, LEIA Health aims to enhance the well-being of new parents during a critical period of their lives.

Charco Neurotech

Seed Round in 2021
Charco Neurotech is a medical technology company focused on creating non-invasive wearable devices aimed at enhancing the quality of life for individuals with Parkinson's disease. The company's primary innovation involves a wearable device that modulates sensory dysfunction, which aids users in improving their movement speed and overall mobility. By addressing specific challenges faced by those living with Parkinson's, Charco Neurotech seeks to empower individuals to maintain a more active and normal lifestyle.

Sanome

Pre Seed Round in 2021
Sanome is a healthcare technology company focused on enhancing clinical decision-making through early detection and prevention of health issues. The company is developing a Clinical Co-pilot that leverages a multimodal generative AI platform to analyze various healthcare data streams and generate actionable insights. By integrating artificial intelligence with biophysical biomarkers, including at-home composite tests, Sanome aims to identify potential health changes before they escalate into serious conditions. This innovative approach is designed to improve patient outcomes and streamline healthcare efficiency by providing clinicians with timely information that can inform their decisions. Ultimately, Sanome envisions creating a human digital twin that continuously monitors individual health, further supporting clinicians in delivering proactive care.

Pear Bio

Seed Round in 2021
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Parallel Health

Pre Seed Round in 2021
Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx

Contextflow

Series A in 2021
Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

Pear Bio

Seed Round in 2020
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Radiobotics

Seed Round in 2020
Radiobotics is a technology company focused on developing advanced machine learning algorithms that assist healthcare professionals in analyzing medical images, particularly x-rays of bones and joints. By automating routine tasks and generating radiology reports, the company's solutions facilitate quicker access to critical diagnostic information, thereby enhancing the quality of medical decision-making. Radiobotics aims to support doctors by streamlining the image analysis process, ultimately contributing to improved patient outcomes through more accurate and timely diagnoses.

Subtle Medical

Series A in 2020
Subtle Medical, Inc. is a healthcare technology company based in Menlo Park, California, specializing in AI-powered medical imaging solutions. Founded in 2017, the company develops innovative software products such as SubtleMR and SubtlePET, which are designed to enhance image quality in magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. These products utilize proprietary deep learning algorithms to reduce image noise and improve sharpness, thereby increasing efficiency and safety in clinical workflows. Subtle Medical's technology is FDA cleared and CE marked, and it operates on a vendor-agnostic AI infrastructure that integrates seamlessly with existing imaging systems. The company's mission is to enhance the quality, value, and accessibility of medical imaging by lowering costs, reducing imaging time, and minimizing radiation and contrast doses for patients.

Radiobotics

Pre Seed Round in 2020
Radiobotics is a technology company focused on developing advanced machine learning algorithms that assist healthcare professionals in analyzing medical images, particularly x-rays of bones and joints. By automating routine tasks and generating radiology reports, the company's solutions facilitate quicker access to critical diagnostic information, thereby enhancing the quality of medical decision-making. Radiobotics aims to support doctors by streamlining the image analysis process, ultimately contributing to improved patient outcomes through more accurate and timely diagnoses.

Gleamer

Series A in 2020
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Pear Bio

Pre Seed Round in 2020
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Quibim

Seed Round in 2020
Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, focusing on the integration of artificial intelligence in image processing. The company provides advanced solutions for extracting quantitative information from radiological images, which aids in the diagnosis of high-incidence illnesses and evaluates the effects of pharmacological treatments. Quibim Precision®, its comprehensive imaging ecosystem, is utilized by pharmaceutical companies and research teams worldwide for a variety of applications, including disease detection and monitoring treatment efficacy. By leveraging AI technology, Quibim enhances the ability to detect pathologies across all body parts and imaging modalities, ultimately contributing to improved health outcomes.

Ampersand Health

Seed Round in 2020
Ampersand Health is focused on developing digital therapeutics for individuals with long-term inflammatory conditions. Based in London and incorporated in 2014, the company offers a comprehensive digital platform that includes the Ampersand Healthsuite, a management tool designed for patients, and Healthsuite for Clinicians, which supports clinician-led, patient-centered self-management. The platform utilizes behavioral science to deliver personalized therapy, featuring expert-led courses, self-management tracking, and clinical messaging. Ampersand Health aims to enhance patients' mental health and quality of life while also providing significant cost savings for healthcare providers by reducing overall healthcare utilization.

Vitrue Health

Pre Seed Round in 2020
Vitrue Health specializes in digital technology aimed at reducing musculoskeletal issues through accurate measurement and assessment. The company's flagship products, including VIDA and Vitrue EVVA, utilize advanced computer vision and biomechanics to objectively evaluate musculoskeletal health in various settings, from workplaces to clinical environments. VIDA specifically addresses the needs of desk workers by assessing their workspaces and ensuring compliance with ergonomic standards, helping to mitigate common problems like back and neck pain. Vitrue EVVA employs depth sensors for clinical-grade evaluations, which are valuable in orthopaedics, injury prevention in elite sports, and health screenings. By providing detailed reports and predictive insights regarding functional ability and core strength, Vitrue Health empowers both clinicians and patients to identify issues early, design optimal treatment plans, and engage patients in their recovery. The company’s mission is to establish a new foundation for musculoskeletal healthcare, aiming to alleviate pain and improve the quality of life for millions.

Cerebriu

Seed Round in 2020
Cerebriu is a health tech company focused on enhancing medical imaging through advanced machine learning technologies. It specializes in creating a deep-learning-based AI platform that automates image quantification and biomarker indication, providing healthcare professionals with essential real-time decision support during examinations. By improving workflow efficiency and the quality of radiology services, Cerebriu aims to contribute significantly to global healthcare solutions.

Contextflow

Venture Round in 2019
Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

Arthronica

Pre Seed Round in 2019
Arthronica Ltd is a technology company based in London, United Kingdom, focused on developing an artificial intelligence-based platform for patient monitoring and rehabilitation, specifically targeting chronic rheumatic conditions such as arthritis. Founded in 2018, Arthronica's solutions incorporate advanced features such as skeletal tracking, visual strength assessment, image analysis, and video analysis. The company aims to provide medical practitioners with tools to accurately monitor and predict disease activities, thereby enhancing patient care and treatment outcomes. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, and it has participated in the Entrepreneur First program, which supports the growth of technology startups.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.